#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	17040	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2189	773.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1433	1433	C	953	C	900	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	31214	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3542	877.6	0	.	n	.	0	T695C	SNP	695	695	T	1072	1072	C	940	C,T	883,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	31214	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3542	877.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1714	1714	A	1015	A,G	954,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	31214	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3542	877.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2348	2348	C	973	C	910	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	31214	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3542	877.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2422	2422	A	942	A,G	904,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	31214	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3542	877.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2974	2974	C	983	C,T	940,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	2078	folP	852	852	100.0	folP.l15.c17.ctg.1	1592	130.0	1	SNP	p	R228S	1	.	.	682	684	AGC	1096	1098	AGC	198;199;205	A;G;C	186;189;190	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5342	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3345	158.9	1	SNP	p	S91F	0	.	.	271	273	TCC	522	524	TCC	204;202;203	T;C;C	187;185;189	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5342	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3345	158.9	1	SNP	p	D95G	0	.	.	283	285	GAC	534	536	GAC	209;212;213	G;A;C	194;194;198	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5342	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3345	158.9	1	SNP	p	D95N	0	.	.	283	285	GAC	534	536	GAC	209;212;213	G;A;C	194;194;198	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1196	mtrR	633	633	97.47	mtrR.l15.c4.ctg.1	1368	87.2	0	.	p	.	0	D79N	NONSYN	235	237	GAT	653	655	AAT	146;150;151	A;A;T	141;143;144	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1196	mtrR	633	633	97.47	mtrR.l15.c4.ctg.1	1368	87.2	0	.	p	.	0	A86T	NONSYN	256	258	GCG	674	676	ACG	169;170;170	A;C;G	155;158;155	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1196	mtrR	633	633	97.47	mtrR.l15.c4.ctg.1	1368	87.2	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	731	733	CAC	186;188;190	C;A;C	172;168;175	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1196	mtrR	633	633	97.47	mtrR.l15.c4.ctg.1	1368	87.2	0	.	p	.	0	S183N	NONSYN	547	549	AGT	965	967	AAT	82;83;84	A;A;T	81;81;81	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1196	mtrR	633	633	97.47	mtrR.l15.c4.ctg.1	1368	87.2	0	.	p	.	0	M197I	NONSYN	589	591	ATG	1007	1009	ATA	77;81;84	A;T;A	73;74;77	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1196	mtrR	633	633	97.47	mtrR.l15.c4.ctg.1	1368	87.2	1	SNP	p	G45D	0	.	.	133	135	GGC	551	553	GGC	185;183;186	G;G;C,T	178;175;176,1	mtrR.WHO_F_01564:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	4	mtrR_promoter	250	218	100.0	mtrR_promoter.l15.c4.ctg.1	218	1.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5438	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3028	179.0	1	SNP	p	D86N	0	.	.	256	258	GAC	593	595	GAC	231;228;231	G;A;C	217;209;215	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5438	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3028	179.0	1	SNP	p	S87I	0	.	.	259	261	AGT	596	598	AGT	233;230;230	A;G;T	215;214;212	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5438	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3028	179.0	1	SNP	p	S87W	0	.	.	259	261	AGT	596	598	AGT	233;230;230	A;G;T	215;214;212	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5438	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3028	179.0	1	SNP	p	S87R	0	.	.	259	261	AGT	596	598	AGT	233;230;230	A;G;T	215;214;212	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5438	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3028	179.0	1	SNP	p	S88P	0	.	.	262	264	TCC	599	601	TCC	227;225;225	T;C;C	212;210;210	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4538	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2562	176.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1532	1534	GGC	223;221;220	G;G;C	210;205;209	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	4388	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2472	176.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1326	1328	GCA	235;233;235	G;C,G;A	216;208,1;219	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4388	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2472	176.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1329	1331	ATC	240;237;240	A;T;C	222;221;221	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4388	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2472	176.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1341	1343	GTG	234;235;236	G;T;G	216;218;221	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4388	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2472	176.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1341	1343	GTG	234;235;236	G;T;G	216;218;221	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4388	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2472	176.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1845	1847	ACC	229;231;232	A;C;C	211;215;214	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4388	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2472	176.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1899	1901	GCG	206;204;204	G;C,G;G	181;164,1;176	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4388	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2472	176.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1899	1901	GCG	206;204;204	G;C,G;G	181;164,1;176	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4388	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2472	176.9	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2022	2024	GGC	149;148;146	G;G;C	141;139;137	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4388	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2472	176.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2031	2033	GGC	140;140;140	G;G;C	127;125;125	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4388	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2472	176.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2049	2051	CCG	125;126;130	C,G;C,G;G,GGC	99,2;102,1;103,1	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6444	ponA	2397	2397	99.96	ponA.l6.c30.ctg.1	3075	208.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2400	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1906	125.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	553	553	C	167	C	154	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3296	porB1b	1038	1038	99.52	porB1b.l6.c4.ctg.1	1608	203.9	0	.	p	.	0	I45V	NONSYN	133	135	ATT	507	509	GTT	254;255;257	G;T;T	246;241;246	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3296	porB1b	1038	1038	99.52	porB1b.l6.c4.ctg.1	1608	203.9	0	.	p	.	0	I75V	NONSYN	223	225	ATT	597	599	GTT	274;276;278	G,A;T;T	251,1;248;258	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3296	porB1b	1038	1038	99.52	porB1b.l6.c4.ctg.1	1608	203.9	0	.	p	.	0	S89T	NONSYN	265	267	AGC	639	641	ACC	266;263;262	A;C,G;C	240;242,1;239	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3296	porB1b	1038	1038	99.52	porB1b.l6.c4.ctg.1	1608	203.9	0	.	p	.	0	I98V	NONSYN	292	294	ATC	666	668	GTC	260;255;249	G,A;T;C	232,1;226;225	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3296	porB1b	1038	1038	99.52	porB1b.l6.c4.ctg.1	1608	203.9	1	SNP	p	G120K	1	.	.	358	360	AAG	732	734	AAG	255;252;251	A;A;G	240;236;235	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3296	porB1b	1038	1038	99.52	porB1b.l6.c4.ctg.1	1608	203.9	1	SNP	p	N121D	0	.	.	361	363	AAC	735	737	AAC	251;256;256	A;A;C,T	233;239;238,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3296	porB1b	1038	1038	99.52	porB1b.l6.c4.ctg.1	1608	203.9	1	SNP	p	A121N	1	.	.	361	363	AAC	735	737	AAC	251;256;256	A;A;C,T	233;239;238,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12602	rpoB	4179	4179	100.0	rpoB.l15.c30.ctg.1	5039	249.4	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2169	2171	AAT	267;263;264	A,C;A;T,A	257,1;254;252,1	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1222	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	984	122.9	1	SNP	p	V57M	1	.	.	169	171	ATG	478	480	ATG	258;258;253	A;T;G	241;240;235	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
